FDA Approved: BUTRANS — Original Application (Purdue Pharma LP)

View source ↗

Summary

FDA approved Purdue Pharma's original NDA for BUTRANS, a buprenorphine transdermal patch, for the treatment of moderate to severe chronic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• BUTRANS (Buprenorphine)

Snippet

ORIG AP for BUTRANS (BUPRENORPHINE)